CORC

浏览/检索结果: 共26条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Second-generation EGFR and ErbB tyrosine kinase inhibitors as first-line treatments for non-small cell lung cancer 期刊论文
2019, 卷号: 12, 页码: 6535-6548
作者:  Wang, Shouzheng;  Li, Junling
收藏  |  浏览/下载:47/0  |  提交时间:2020/01/03
Comparative review of drug-drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer 期刊论文
2019, 卷号: 12, 页码: 5467-5484
作者:  Xu, Zi-Yi;  Li, Jun-Ling
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/03
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 36
作者:  Zhou, Ming;  Chen, Xiaoyuan;  Zhang, Hong;  Xia, Lin;  Tong, Xin
收藏  |  浏览/下载:29/0  |  提交时间:2020/01/03
Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy or non-small cell lung cancer 期刊论文
2019, 卷号: 11, 期号: 5, 页码: 1779-+
作者:  Liu, Yu-Tao;  Han, Xiao-Hong;  Xing, Pu-Yuan;  Hu, King-Sheng;  Hao, Xue-Zhi
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
Antitumor activity of histone deacetylase inhibitor chidamide alone or in combination with epidermal growth factor receptor tyrosine kinase inhibitor icotinib in NSCLC 期刊论文
2019, 卷号: 10, 期号: 5, 页码: 1275-1287
作者:  Zhang, Ningning;  Liang, Caixia;  Song, Wenya;  Tao, Dan;  Yao, Jiarui
收藏  |  浏览/下载:8/0  |  提交时间:2020/01/03
Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer 期刊论文
2019, 卷号: 42, 页码: 304-310
作者:  Chen, Minjiang;  Xu, Yan;  Zhao, Jing;  Zhong, Wei;  Zhang, Li
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs 期刊论文
2018, 卷号: 97, 期号: 30, 页码: e11648
作者:  Zhang, Yuan;  Feng, Yang-Chun;  Zhu, Hong-Ge;  Xiong, Ting-Chuan;  Hou, Yan-Shen
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment 期刊论文
2018, 卷号: 11, 页码: 6189-6196
作者:  Liang, Hongge;  Liu, Xiaoyan;  Wang, Mengzhao
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study 期刊论文
2018, 卷号: 9, 期号: 11, 页码: 1461-1469
作者:  Cheng, Ying;  Wang, Yan;  Zhao, Jun;  Liu, Yunpeng;  Gao, Hongjun
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/03
Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) 期刊论文
2017, 卷号: 12, 期号: 12, 页码: 1766-1778
作者:  Zhong, Jia;  Li, Lei;  Wang, Zhijie;  Bai, Hua;  Gai, Fei
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace